Adaptive Biotechnologies Corp - Common stock, par value $0.0001 per share (ADPT)

5 filings reported holding ADPT - Adaptive Biotechnologies Corp - Common stock, par value $0.0001 per share as of Q4 2023.
Adaptive Biotechnologies Corp - Common stock, par value $0.0001 per share (ADPT) has 4 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 269K shares of 152M outstanding shares and own 0.18% of the company stock.
Largest 10 shareholders include VIKING GLOBAL INVESTORS LP (30M shares), ARK Investment Management LLC (12.8M shares), VANGUARD GROUP INC (12.8M shares), Matrix Capital Management Company, LP (11.6M shares), BlackRock Inc. (11.4M shares), Sumitomo Mitsui Trust Holdings, Inc. (6.51M shares), Nikko Asset Management Americas, Inc. (6.51M shares), Point72 Asset Management, L.P. (3.72M shares), Pictet Asset Management Holding SA (3.42M shares), and Aristotle Atlantic Partners, LLC (3.05M shares).
This table shows the top 4 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.